Tagged With Gilead Science

2 biotech stocks plummet more than 25% after the FDA rejects their drug applications


US stocks fluctuate as traders weigh virus spike against advances in treatment


Gilead rises after pricing its coronavirus-fighting drug remdesivir



Regeneron widens its lead as the S&P 500's top performer after saying key COVID-19 drug may be available in the fall


Dow surges 500 points on optimism around US economic reopening plan


Gilead surges 17% on report that drug shows effectiveness against COVID-19



The family of a 34-year-old father in a 2-week coma with COVID-19 says a 'bureaucratic glitch' has kept him from accessing potentially life-saving treatment